IXOPHARMA LTD
Owned by Professor Jonathan Austyn and Professor Patricia Anne Nuttall
Summary
IXOPHARMA LTD is an active private limited company (company number 16796547) incorporated on 20 October 2025, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). No accounts have been filed yet; the first accounts are due by 20 July 2027.
There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.
Key dates
- Incorporated
- 20 October 20251 yr ago
- First accounts due
- 20 July 2027in 271 days
- Confirmation statement due
- 3 November 2026in 12 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- No Accounts Filed
Financials
No accounts filed yet. The first accounts are due by 20 July 2027; this page updates when they are filed.
Ownership and control
- Professor Jonathan Austyn
- owns 25–50% of shares
- holds 25–50% of voting rights
- Professor Patricia Anne Nuttall
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Timeline
- First accounts duein 271 days
- Confirmation statement duein 12 days
- Incorporated
Similar companies in London
- DISOLENS LTDLondon · inc. Oct 2025
- PARIS BIO LIMITEDLondon · inc. Oct 2025
- MGB CONSULTING SERVICES LTDLondon · inc. Oct 2025
- KLONA BIOTECH LIMITEDLondon · inc. Oct 2025
- LORETTA HEALTH LTDLondon · inc. Oct 2025
- SYNOME BIOSCIENCES LIMITEDLondon · inc. Oct 2025
All companies incorporated on 20 October 2025 · in Oct 2025.
Reminders for IXOPHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.